
Supriya Lifescience Limited – NSE:SUPRIYA.NS
Supriya Lifescience Limited stock price today
Supriya Lifescience Limited stock price monthly change
Supriya Lifescience Limited stock price quarterly change
Supriya Lifescience Limited stock price yearly change
Supriya Lifescience Limited key metrics
Market Cap | 57.22B |
Enterprise value | 55.90B |
P/E | 36.10 |
EV/Sales | 8.94 |
EV/EBITDA | 23.86 |
Price/Sales | 9.06 |
Price/Book | 6.27 |
PEG ratio | 0.36 |
EPS | 14.8 |
Revenue | 5.70B |
EBITDA | 1.81B |
Income | 1.19B |
Revenue Q/Q | 11.18% |
Revenue Y/Y | 23.74% |
Profit margin | 25.2% |
Oper. margin | 33.61% |
Gross margin | 55.57% |
EBIT margin | 33.61% |
EBITDA margin | 31.85% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSupriya Lifescience Limited stock price history
Supriya Lifescience Limited stock forecast
Supriya Lifescience Limited financial statements
Jun 2023 | 1.32B | 285.11M | 21.6% |
---|---|---|---|
Sep 2023 | 1.40B | 238.84M | 17.05% |
Dec 2023 | 1.40B | 297.87M | 21.27% |
Mar 2024 | 1.58B | 369.32M | 23.35% |
2026 | 8.57B | 1.94B | 22.65% |
---|---|---|---|
2027 | 11.14B | 2.66B | 23.88% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 0% |
---|
2019 | |
---|---|
2020 | 0.62% |
2022 | 0.11% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 8430300000 | 898.57M | 10.66% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 9212380000 | 1.05B | 11.49% |
Mar 2023 | 60.14M | 0 | 0 |
---|---|---|---|
Jun 2023 | 79.1M | 0 | 0 |
Sep 2023 | 79.62M | 0 | 0 |
Dec 2023 | 79.2M | 0 | 0 |
Supriya Lifescience Limited alternative data
Aug 2023 | 356 |
---|---|
Sep 2023 | 356 |
Oct 2023 | 392 |
Nov 2023 | 392 |
Dec 2023 | 392 |
Jan 2024 | 392 |
Feb 2024 | 392 |
Mar 2024 | 392 |
Apr 2024 | 392 |
May 2024 | 392 |
Jun 2024 | 392 |
Jul 2024 | 392 |
Supriya Lifescience Limited other data
-
What's the price of Supriya Lifescience Limited stock today?
One share of Supriya Lifescience Limited stock can currently be purchased for approximately $478.35.
-
When is Supriya Lifescience Limited's next earnings date?
Unfortunately, Supriya Lifescience Limited's (SUPRIYA.NS) next earnings date is currently unknown.
-
Does Supriya Lifescience Limited pay dividends?
Yes, Supriya Lifescience Limited pays dividends and its trailing 12-month yield is 0.11% with 0% payout ratio. The last Supriya Lifescience Limited stock dividend of undefined was paid on 5 Sep 2025.
-
How much money does Supriya Lifescience Limited make?
Supriya Lifescience Limited has a market capitalization of 57.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.82% to 5.7B US dollars.
-
What is Supriya Lifescience Limited's stock symbol?
Supriya Lifescience Limited is traded on the NSE under the ticker symbol "SUPRIYA.NS".
-
What is Supriya Lifescience Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Supriya Lifescience Limited?
Shares of Supriya Lifescience Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Supriya Lifescience Limited have?
As Jul 2024, Supriya Lifescience Limited employs 392 workers.
-
When Supriya Lifescience Limited went public?
Supriya Lifescience Limited is publicly traded company for more then 3 years since IPO on 28 Dec 2021.
-
What is Supriya Lifescience Limited's official website?
The official website for Supriya Lifescience Limited is supriyalifescience.com.
-
How can i contact Supriya Lifescience Limited?
Supriya Lifescience Limited can be reached via phone at +91 22 4033 2727.
Supriya Lifescience Limited company profile:

Supriya Lifescience Limited
supriyalifescience.comNSE
448
Biotechnology
Healthcare
Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, anti–hypertensive, and anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals. The company was founded in 1987 and is headquartered in Mumbai, India.
Mumbai, 400063
:
ISIN: INE07RO01027
: